AHA Urges USP to Delay Effective Dates for New Guidelines

AHA today urged the United States Pharmacopeial Convention to delay by at least 18 months the effective dates for its general chapter <797> pharmaceutical compounding and general chapter <800> hazardous drug handling in health care settings, as well as proposed revisions to general chapter <797>. “USP guidelines play a critical role in keeping our hospital staffs and the patients they care for safe,” AHA wrote. “However, we reiterate concerns we have previously shared regarding the compliance challenges that these two sections create.” Specifically, the proposed changes to general chapter <797> may impact or modify efforts by hospitals and health systems to comply with chapter <800>; the guidelines involve large capital investments, in some cases the construction of entirely new buildings; and the timeline has resulted in high demand for contractors and supplies, making it very challenging for all facilities to comply by the effective date, AHA said. The association also commended USP for simplifying many provisions in its September redraft of general chapter <797>, but shared some concerns regarding the beyond-use dates, repackaging and temperature metrics.

Related Resources

Amicus Brief
Public
The AHA and Federation of American Hospitals today urged the U.S.
Letter
On behalf of the nearly 5,000 member hospitals, health systems and other health care organizations, and our clinician partners – including more than 270,000…
Letter
Public
AHA comments on HHS' request for information on modifying Health Insurance Portability and Accountability Act of 1996 (HIPAA) rules to improve coordinated care.
Case Studies
Public
Montefiore Health System uses the Collaborative Care Model to better serve patients with significant medical and mental health conditions and socioeconomic…
Letter
Public
AHA comments on draft report from the Office of the National Coordinator for Health Information Technology entitled “Strategy on Reducing Regulatory and…
Letter
Public
The Federal Trade Commission’s approach to reviewing hosp